首页> 外文期刊>Asian Pacific Journal of Cancer Prevention >Coenzyme Complex Decreased Cardiotoxicity When Combined with Chemotherapy in Treating Elderly Patients with Gastrointestinal Cancer
【24h】

Coenzyme Complex Decreased Cardiotoxicity When Combined with Chemotherapy in Treating Elderly Patients with Gastrointestinal Cancer

机译:结合化疗时,辅酶复合物在治疗胃肠道癌症治疗老年患者时降低

获取原文
           

摘要

Objective: To investigate the effect of coenzyme complex on decreasing cardiotoxicity in elderly patients with gastrointestinal cancer who were treated by chemotherapy. Methods: From September 2011 to February 2015, we recruited 54 elderly (with more than 70 years of age) patients with gastrointestinal cancer, with advanced disease. Then treated with chemotherapy combined with or without coenzyme complex. After two cycles of treatment, the effect of coenzyme complex on decreasing cardiotoxicity were evaluated. Results: Chemotherapy was combined with coenzyme complex in 32 patients (22man, 10 woman; median age: 74 years, range: 70-87 years) without coenzyme complex in 22 patients (15man, 7 woman; median age: 73 years, range: 70-80 years) with gastrointestinal cancer. Cardiac event was significantly lower in patients treated with chemotherapy combined with coenzyme complex (p0.01). Conclusions: Coenzyme Complex decreased cardiotoxicity when combined with chemotherapy in treating elderly patients with gastrointestinal cancer.
机译:目的:探讨辅酶复合体对化疗治疗后老年胃肠癌患者心脏毒性的影响。方法:2011年9月至2015年2月,我们招募了54名老年人(超过70岁)胃肠癌患者,具有晚期疾病。然后用化疗与或没有辅酶络合物进行处理。在两次治疗后,评价辅酶复合物对降低心脏毒性的影响。结果:化疗与32例患者中辅酶综合体相结合(22man,10名女性;中位数:74岁,范围:70-87岁)在22例患者中没有辅酶综合体(15man,7名女子;中位数:73岁,范围: 70-80岁)胃肠癌。化疗治疗的患者与辅酶复合物合并(P <0.01),心脏事件显着降低。结论:与化疗结合化疗治疗胃肠道癌的老年患者时,辅酶复合物减少。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号